NCT06816108 2026-01-12A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid TumorsOno Pharmaceutical Co. LtdPhase 1 Recruiting60 enrolled
NCT02959619 2023-08-21Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALKBetta Pharmaceuticals Co., Ltd.Phase 1 Completed48 enrolled